Coherus BioSciences, Inc.【CHRS】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
4Q25
|
-37,643
|
-25.7%
|
|
3Q25
|
-35,531
|
+230.5%
|
|
2Q25
|
297,767
|
-2404.5%
|
|
1Q25
|
-56,569
|
-155.0%
|
|
4Q24
|
-50,696
|
-36.4%
|
|
3Q24
|
-10,751
|
-72.9%
|
|
2Q24
|
-12,921
|
-69.9%
|
|
1Q24
|
102,875
|
-235.8%
|
|
4Q23
|
-79,653
|
+35.3%
|
|
3Q23
|
-39,641
|
-54.3%
|
|
2Q23
|
-42,869
|
-14.5%
|
|
1Q23
|
-75,729
|
-21.2%
|
|
4Q22
|
-58,870
|
+28.7%
|
|
3Q22
|
-86,650
|
+124.9%
|
|
2Q22
|
-50,150
|
+67.7%
|
|
1Q22
|
-96,084
|
-44.4%
|
|
4Q21
|
-45,725
|
-573.1%
|
|
3Q21
|
-38,528
|
-237.9%
|
|
2Q21
|
-29,900
|
-150.7%
|
|
1Q21
|
-172,947
|
-585.8%
|
|
4Q20
|
9,664
|
-75.4%
|
|
3Q20
|
27,933
|
-40.6%
|
|
2Q20
|
59,031
|
+150.5%
|
|
1Q20
|
35,600
|
-278.0%
|
|
4Q19
|
39,227
|
-162.7%
|
|
3Q19
|
47,043
|
-180.0%
|
|
2Q19
|
23,567
|
-154.0%
|
|
1Q19
|
-20,004
|
-54.8%
|
|
4Q18
|
-62,596
|
+27.6%
|
|
3Q18
|
-58,808
|
-0.3%
|
|
2Q18
|
-43,638
|
-21.1%
|
|
1Q18
|
-44,297
|
-40.8%
|
|
4Q17
|
-49,067
|
-35.4%
|
|
3Q17
|
-58,989
|
-170.3%
|
|
2Q17
|
-55,336
|
-20.9%
|
|
1Q17
|
-74,778
|
+14.4%
|
|
4Q16
|
-75,921
|
+44.9%
|
|
3Q16
|
83,939
|
-217.7%
|
|
2Q16
|
-69,967
|
+19.0%
|
|
1Q16
|
-65,388
|
+60.6%
|
|
4Q15
|
-52,391
|
+80.5%
|
|
3Q15
|
-71,334
|
+806.2%
|
|
2Q15
|
-58,810
|
-
|
|
1Q15
|
-40,725
|
-
|
|
4Q14
|
-29,023
|
-
|
|
3Q14
|
-7,872
|
-
|